Kenneth E Palmer

Title: Kenneth E. Palmer: Innovator in Viral Inhibition

Introduction

Kenneth E. Palmer is a notable inventor based in Owensboro, KY (US). He has made significant contributions to the field of viral inhibition through his innovative research and inventions. With a total of 3 patents, Palmer has focused on developing modified polypeptides that can effectively combat viral infections.

Latest Patents

Among his latest patents is the invention of Griffithsin mutants. This invention provides modified griffithsin polypeptides comprising the amino acid sequence of SEQ ID NO: 1. It also includes corresponding nucleic acids, vectors, cells, fusion proteins, constructs, conjugates, and methods of inhibiting viral infection. This work highlights his commitment to advancing medical science and improving public health.

Career Highlights

Throughout his career, Kenneth E. Palmer has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Louisville Research Foundation, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Barry R. O'Keefe and Tinoush Moulaei. Their collaborative efforts have further enhanced the impact of Palmer's inventions and research.

Conclusion

Kenneth E. Palmer's work in developing innovative solutions for viral infections showcases his dedication to scientific advancement. His contributions through patents and collaborations continue to influence the field of virology and public health.